Fiduciary Trust CO Organon & Co. Transaction History

Fiduciary Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$23.31 - $28.61 $37,808 - $46,405	-1,622 Reduced 17.95%	7,414 $207,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $28,056 - $41,065	-1,199 Reduced 11.71%	9,036 $212,000
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $62,180 - $76,399	-1,964 Reduced 16.1%	10,235 $345,000
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $43,452 - $56,166	-1,427 Reduced 10.47%	12,199 $426,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $284,119 - $367,958	-9,910 Reduced 42.11%	13,626 $415,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $417,081 - $519,203	-14,568 Reduced 38.23%	23,536 $772,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $1.08 Million - $1.45 Million	38,104 New	38,104 $1.15 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

Stay updated on Fiduciary Trust CO with notifications on news.